Results 81 to 90 of about 3,169 (181)

New 5-(pyridin-3-yl)-1,3,4-oxadiazoles derivatives as VEGFR2 inhibitors: <i>in silico</i> study, synthesis, and cytotoxicity evaluation. [PDF]

Res Pharm Sci
Abdulhussein AN, Oleiwi MA.
europepmc   +1 more source

Editorial: Advancing treatments for protozoan diseases: from resistance mechanisms to novel therapies. [PDF]

Front Microbiol
Touz MC, Arranz-Solís D, Nardelli S.
europepmc   +1 more source

Conversion of N₂ into oxadiazoles promoted by a multinuclear samarium complex. [PDF]

Nat Commun
Shi X, Yuan Q, Chen Y, Xi Z, Wei J.
europepmc   +1 more source

Synthesis and antimicrobial evaluation of hybrids methoxynaphthalene-<i>N</i>-acylhydrazones/1,3,4-oxadiazoles. [PDF]

Future Med Chem
Frederico Rozada AM, Maçon C, Santos JLA, Ferreira RM, da Motta Dacome MLF, Mendes RP, Vicente Seixas FA, Caleffi K, Basso EA, de Freitas Gauze Bandoch G.   +9 more
europepmc   +1 more source

Greening of Monocyclic N- and O‑Azole Synthesis through Sonochemistry. [PDF]

ACS Omega
Hoffman GR, Saeed MM, Schoffstall AM.
europepmc   +1 more source

Tri-1,3,4-Oxadiazoles Modified with Nitroimine: Balancing Energy, Sensitivity, and Thermal Stability. [PDF]

Molecules
Chen F, Yu Q, Li L, Peng K, Zhu C, Yi W.
europepmc   +1 more source

In vivo anti-inflammatory evaluation of oxadiazole derivatives bearing flurbiprofen moiety using experimental and computational approaches. [PDF]

Sci Rep
Shaheen K, Alam A, Elhenawy AA, Khan IA, Rahman FU, Ali A, Rehman MU, AlAsmari AF, Alasmari F, Ahmad M, Khan M.   +10 more
europepmc   +1 more source

Design, synthesis and antiproliferative, apoptotic, and immunomodulatory properties of new heteroaryl pyridine-linked 1,2,4-oxadiazoles as prospective dual EGFR/BRAF^V600E inhibitors. [PDF]

RSC Adv
Gomaa HAM, Shaker ME, Alzarea SI, Alatwi E, Mohamed FAM, Abdullah Alzahrani AY, Alyami BA, Bräse S, Rabea SM, Youssif BGM.   +9 more
europepmc   +1 more source

<i>One-pot</i> dearomatizative telescoped addition of <i>C</i>-nucleophiles to fluorinated 1,2,4-oxadiazoles followed by regioselective <i>N</i>-functionalization.

Org Chem Front
Castiglione D, Amata S, Lauria F, Maranzana A, Baldino S, Prado-Roller A, Castoldi L, Palumbo Piccionello A, Pace V, Comas Iwasita EI.   +9 more
europepmc   +1 more source

Development of Photopolymerizable Implants for Controlled Release of Pro-Apoptotic 1,2,4-Oxadiazoles. [PDF]

ACS Omega
Aciole RCG, Lima MJS, de Oliveira EB, Santos DKDN, Aguiar JS, Alves S, Dos Anjos JV.   +6 more
europepmc   +1 more source